Recent developments in health and medicine cover clinical research findings, FDA safety warnings, and public health crises.
Key Points
Research presented at the American Thoracic Society 2026 suggests the 90-day CPAP adherence window used by CMS for coverage eligibility is prematurely restrictive, as many patients reach success within a year.
The FDA has issued an updated warning for the cosmetic injectable Kybella, highlighting emerging risks of facial numbness, weakness, nodules, and masses.
New food allergy blood tests, while promising, currently face logistical barriers that prevent them from replacing the standard oral food challenge in routine clinical practice.
A study indicates that nurse-led digital therapeutics programs significantly improve medication adherence and metabolic health markers for adults with type 2 diabetes.
Primary care interventions led by nurses have been shown to effectively improve asthma control for pediatric patients aged 6 to 12 years.
Clinical data suggests that the drug dupilumab provides significant relief for patients suffering from severe chronic rhinosinusitis with nasal polyps and associated ear inflammation.
New research warns that performing cesarean sections for very early preterm births is associated with a higher incidence of severe maternal complications compared to vaginal delivery.
A severe public health incident in Nigeria's Ondo state has resulted in at least 49 deaths and 182 hospitalizations linked to suspected alcohol poisoning.